Health
Sacubitril/Valsartan Treatment for HFpEF Shown to Reduce NT-proBNP Levels – AJMC.com Managed Markets Network
Wanting more data on the benefits of sacubitril/valsartan vs renin angiotensin system inhibitor background therapy, investigators…
Among several measures evaluated in a 24-week, randomized, double-blind, parallel group clinical trial comparing outcomes among patients with heart failure with preserved ejection fraction (HFpEF; left ventricular ejection fraction > 40%), sacubitril/valsartan…
Continue Reading
-
Noosa News22 hours agoWhy Brisbane needs to (re)embrace Los Angeles
-
General22 hours agoUK names Sarah Mullally as first female Archbishop of Canterbury to lead Church of England
-
General22 hours agoSussan Ley responds to Andrew Hastie’s Shadow Cabinet resignation
-
Noosa News20 hours agoTayla Harris stars as Melbourne defeats Essendon by 14 points